CHOREA, HUNTINGTON

Clinical trials for CHOREA, HUNTINGTON explained in plain language.

Never miss a new study

Get alerted when new CHOREA, HUNTINGTON trials appear

Sign up with your email to follow new studies for CHOREA, HUNTINGTON, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Huntington's chorea: valbenazine safety trial expands

Symptom relief ENROLLING_BY_INVITATION

This study looks at the long-term safety of valbenazine for treating chorea (involuntary movements) in people with Huntington disease. It is for 7 participants in Canada who were in a previous valbenazine study. The main goal is to track any side effects over time.

Matched conditions: CHOREA, HUNTINGTON

Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief

Last updated May 14, 2026 12:04 UTC

CHOREA, HUNTINGTON

Get alerted when new CHOREA, HUNTINGTON trials appear

New hope for Huntington's chorea: valbenazine safety trial expands